Transcriptional repression of telomerase RNA gene expression by c-Jun-NH2-kinase and Sp1/Sp3

被引:30
作者
Bilsland, AE
Stevenson, K
Atkinson, S
Kolch, W
Keith, WN
机构
[1] Canc Res UK Beatson Labs, Glasgow G61 1BD, Lanark, Scotland
[2] Univ Glasgow, Ctr Oncol & Appl Pharmacol, Glasgow G12 8QQ, Lanark, Scotland
[3] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
关键词
D O I
10.1158/0008-5472.CAN-05-1941
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Telomerase is essential for immortalization of most human cancer cells. Expression of the core telomerase RNA (hTR) and reverse transcriptase (hTERT) subunits is mainly regulated by transcription. However, hTR transcriptional regulation remains poorly understood. We previously showed that the core hTR promoter is activated by Sp1 and is repressed by Sp3. Here, we show that the mitogen-activated protein kinase kinase kinase 1 (MEKK1)/c-Jun-NH2-kinase (JNK) pathway represses hTR expression by a mechanism that involves Sp1 and Sp3. Promoter activity was induced by the JNK inhibitor SP600125 and was repressed by activated MEKK1. Repression by MEKK1 was blocked by SP600125 or enhanced by coexpression of wild-type but not phosphoacceptor mutated JNK. SP600125 treatment also increased levels of endogenous hTR. Mutations in the hTR promoter Sp1/Sp3 binding sites attenuated SP600125-mediated promoter induction, whereas coexpression of MEKK1 with Sp3 enhanced hTR promoter repression. Chromatin immunoprecipitation showed that levels of immunoreactive Sp1 associated with the promoter were low in comparison with Sp3 in control ells but increased after JNK inhibition with a reciprocal decrease in Sp3 levels. No corresponding changes in Sp1/Sp3 protein levels were detected. Thus, JNK represses hTR promoter activity and expression, apparently by enhancing repression through Sp3.
引用
收藏
页码:1363 / 1370
页数:8
相关论文
共 45 条
  • [1] Casein kinase II-mediated phosphorylation of the C terminus of spl decreases its DNA binding activity
    Armstrong, SA
    Barry, DA
    Leggett, RW
    Mueller, CR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (21) : 13489 - 13495
  • [2] Reconstitution of human telomerase activity and identification of a minimal functional region of the human telomerase RNA
    Autexier, C
    Pruzan, R
    Funk, WD
    Greider, CW
    [J]. EMBO JOURNAL, 1996, 15 (21) : 5928 - 5935
  • [3] Functional regions of human telomerase reverse transcriptase and human telomerase RNA required for telomerase activity and RNA-protein interactions
    Bachand, F
    Autexier, C
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (05) : 1888 - 1897
  • [4] MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription
    Benasciutti, E
    Pagès, G
    Kenzior, O
    Folk, W
    Blasi, F
    Crippa, MP
    [J]. BLOOD, 2004, 104 (01) : 256 - 262
  • [5] Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase
    Bilsland, AE
    Anderson, CJ
    Fletcher-Monaghan, AJ
    McGregor, F
    Evans, TRJ
    Ganly, I
    Knox, RJ
    Plumb, JA
    Keith, WN
    [J]. ONCOGENE, 2003, 22 (03) : 370 - 380
  • [6] Growth/cell cycle regulation of Sp1 phosphorylation
    Black, AR
    Jensen, D
    Lin, SY
    Azizkhan, JC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (03) : 1207 - 1215
  • [7] Telomere shortening and tumor formation by mouse cells lacking telomerase RNA
    Blasco, MA
    Lee, HW
    Hande, MP
    Samper, E
    Lansdorp, PM
    DePinho, RA
    Greider, CW
    [J]. CELL, 1997, 91 (01) : 25 - 34
  • [8] hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents.
    Brown, R
    Hirst, GL
    Gallagher, WM
    McIlwrath, AJ
    Margison, GP
    vanderZee, AGJ
    Anthoney, DA
    [J]. ONCOGENE, 1997, 15 (01) : 45 - 52
  • [9] EGF stimulates gastrin promoter through activation of Sp1 kinase activity
    Chupreta, S
    Du, M
    Todisco, A
    Merchant, JL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2000, 278 (04): : C697 - C708
  • [10] Cui W, 2000, MOL CARCINOGEN, V29, P219, DOI 10.1002/1098-2744(200012)29:4<219::AID-MC1004>3.0.CO